Organogenesis Holdings Inc. Reports Fourth Quarter 2022 and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Guidance

Go back to Organogenesis Holdings Inc. Reports Fourth Quarter 2022 and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Guidance
(NASDAQ: ORGO) Delayed: 1.40 --0 (-0%)
Previous Close $1.40    52 Week High
Open $1.40    52 Week Low
Day High $1.40    P/E N/A 
Day Low $1.40    EPS
Volume 979